WO2003020874A2 - Improved method for freezing viable cells - Google Patents
Improved method for freezing viable cells Download PDFInfo
- Publication number
- WO2003020874A2 WO2003020874A2 PCT/IL2002/000738 IL0200738W WO03020874A2 WO 2003020874 A2 WO2003020874 A2 WO 2003020874A2 IL 0200738 W IL0200738 W IL 0200738W WO 03020874 A2 WO03020874 A2 WO 03020874A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- vessel
- sample
- freezing
- cells
- track
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L7/00—Heating or cooling apparatus; Heat insulating devices
- B01L7/54—Heating or cooling apparatus; Heat insulating devices using spatial temperature gradients
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0236—Mechanical aspects
- A01N1/0242—Apparatuses, i.e. devices used in the process of preservation of living parts, such as pumps, refrigeration devices or any other devices featuring moving parts and/or temperature controlling components
- A01N1/0252—Temperature controlling refrigerating apparatus, i.e. devices used to actively control the temperature of a designated internal volume, e.g. refrigerators, freeze-drying apparatus or liquid nitrogen baths
- A01N1/0257—Stationary or portable vessels generating cryogenic temperatures
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0278—Physical preservation processes
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F25—REFRIGERATION OR COOLING; COMBINED HEATING AND REFRIGERATION SYSTEMS; HEAT PUMP SYSTEMS; MANUFACTURE OR STORAGE OF ICE; LIQUEFACTION SOLIDIFICATION OF GASES
- F25D—REFRIGERATORS; COLD ROOMS; ICE-BOXES; COOLING OR FREEZING APPARATUS NOT OTHERWISE PROVIDED FOR
- F25D3/00—Devices using other cold materials; Devices using cold-storage bodies
- F25D3/02—Devices using other cold materials; Devices using cold-storage bodies using ice, e.g. ice-boxes
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F26—DRYING
- F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
- F26B5/00—Drying solid materials or objects by processes not involving the application of heat
- F26B5/04—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum
- F26B5/06—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum the process involving freezing
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F25—REFRIGERATION OR COOLING; COMBINED HEATING AND REFRIGERATION SYSTEMS; HEAT PUMP SYSTEMS; MANUFACTURE OR STORAGE OF ICE; LIQUEFACTION SOLIDIFICATION OF GASES
- F25C—PRODUCING, WORKING OR HANDLING ICE
- F25C1/00—Producing ice
- F25C1/18—Producing ice of a particular transparency or translucency, e.g. by injecting air
- F25C1/20—Producing ice of a particular transparency or translucency, e.g. by injecting air by agitation
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F25—REFRIGERATION OR COOLING; COMBINED HEATING AND REFRIGERATION SYSTEMS; HEAT PUMP SYSTEMS; MANUFACTURE OR STORAGE OF ICE; LIQUEFACTION SOLIDIFICATION OF GASES
- F25D—REFRIGERATORS; COLD ROOMS; ICE-BOXES; COOLING OR FREEZING APPARATUS NOT OTHERWISE PROVIDED FOR
- F25D3/00—Devices using other cold materials; Devices using cold-storage bodies
- F25D3/10—Devices using other cold materials; Devices using cold-storage bodies using liquefied gases, e.g. liquid air
- F25D3/11—Devices using other cold materials; Devices using cold-storage bodies using liquefied gases, e.g. liquid air with conveyors carrying articles to be cooled through the cooling space
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/42—Low-temperature sample treatment, e.g. cryofixation
Definitions
- the present invention relates to the storage of living cells and in particular relates to a method of. and device for, freezing living cells.
- the method can be applied to freeze high volume samples or for the freezing as a preparatory step preceding lyophilization.
- the cells be held in a state of suspended animation, a state wherein cell metabolism is entirely stopped. When needed, the cells are reanimated and used. Cells such as spermatozoa, blood and blood products are amongst the cell types for which long term storage is desired.
- a generally accepted way of storing cells in a state of suspended animation is cryopreservation. Most simply, a sample containing viable cells is quickly cooled, for example by immersion in liquid nitrogen, to freeze the sample. When thawed under carefully controlled conditions acceptable levels of post-thaw cell viability are achieved.
- cryopreservation of cells involves the difficulties in maintaining the frozen state. Refrigeration at cryogenic temperatures of 198K is necessarily expensive (excepting in the Antarctic) and not a perfect solution as biological activity does not cease until about 143K. The bulk of the required refrigeration systems renders cryopreserved cells not easily transportable.
- An additional method for storing cells in a state of suspended animation involves removing a significant proportion of water from the cells (drying).
- dry cells can potentially be stored at close to room temperatures without requiring bulky and expensive storage devices.
- cells are air-dried: the cells in solution are spread out in a thin layer and water allowed to evaporate.
- air drying has not been shown to be a practical method for the preservation of large-volume samples. Post-rehydration viability of air-dried cells is incidental at best. Apparently, either the air-drying process or the rehydration process causes cytolysis.
- Another approach for drying cells involves freeze-drying.
- the simplest methods involve lyophilization of a frozen sample. Post-rehydration viability is poor.
- cryoprotectants are antifreeze molecules and includes dimethyl sulfoxide (DMSO), glycerol and related polyhydril alcohols (e.g. propylene or ethylene glycol).
- DMSO dimethyl sulfoxide
- glycerol glycerol
- polyhydril alcohols e.g. propylene or ethylene glycol
- cryoprotectants termed non-permeating or extracellular cryoprotectants, bind to membrane lipids.
- the membrane lipids are stabilized, thus preserving cell-structure integrity.
- cryoprotectants include proline and sugars (e.g. glucose). Crowe (in U.S. 4,857,319) has taught that trehalose is an exceptionally good cryoprotectant.
- cryoprotectants are manifold. Different cell types require different cryoprotectants at different concentrations. Thus the use of cryoprotectants is not a general method but rather requires a complex and time-consuming optimization step. Second, rehydration and thawing must be very carefully due to the effect of osmotic pressure resulting from the presence of cryoprotectants in solution. Lastly, upon rehydration or thawing, the cells are found in an "unnatural" solution which must be purified or modified before being used.
- FIG. 1 Schematically depicted in Figure 1 is a device 10 used to realize the teachings of U.S. 5,873,254.
- a vessel 12 holding a biological sample 14 lays on a track 16.
- Track 16 leads from the surroundings into a cooling device 18.
- Cooling device 18 is substantially a block of a thermally conductive material having a tunnel 20 through which vessel 12 can pass .when guided along track 16.
- In cooling device 18 is maintained a temperature gradient by the use of a plurality of cooling elements 22a, 22b and 22c. The temperature gradient is oriented so that there is a temperature gradient parallel to tunnel 20.
- the temperature of cooling device 18 at entrance 24 of tunnel 20 is typically roughly the temperature of sample 14 at the beginning of the freezing process. Exit 26 of tunnel 20 is cooler than entrance 24.
- a toothed rod 28, a gear 30, configured to engage rod 28, and an electrical motor 32, configured to rotate gear 30, are all elements of a mechanism configured to push vessel 12 into and through tunnel 20 at a controlled rate.
- the cooling rate C (in units of °C/min) is determined by the temperature gradient G (in units of °C/mm) along track 16 and the rate of advancement of the cooling front P (in units of mm/sec) through biological sample 14, determined by the speed which vessel 12 travels through tunnel 20.
- Cells in cryoprotectant-containing samples have exceptional post-thaw viability when frozen according to the method of U.S. 5,873,254, for example by using a device such as device 10. It is important to note that when a biological sample is lyophilized subsequent to freezing according to the method of U.S. 5,873,254, post-rehydration cell viability is insufficient.
- the method of the present invention involves directional cooling of a biological sample, substantially as described hereinabove and in U.S. 5,873,254, but unique in that as biological sample containing vessel advances through the thermal gradient, the vessel is agitated.
- the preferred agitation mode is rotation, the axis of rotation preferably being substantially perpendicular to the direction of advancement.
- a method for freezing cells including confining a sample in a vessel (the vessel having a leading end and a terminal end, the sample containing the cells and having a freezing point) and gradually cooling the sample to below the freezing point so as to generate a temperature gradient in the sample, where during cooling the leading end is cooler than the terminal end so as to generate a freezing front moving from the leading end towards the terminal end where during the gradual cooling the vessel is agitated.
- the agitation is rotation of the vessel about an axis, the axis being substantially perpendicular to the freezing front.
- the vessel is not completely filled with sample, preferably being less than about 90% filled, more preferably less than about 50% filled, and even more preferably less than about 30% filled.
- the partial filling of the vessel by sample leads to a frozen sample with a large surface area and a crystal structure that allows for simple lyophilization and for exceptional post-rehydration viability of thus freeze-dried cells.
- a method for storing viable freeze dried cells by freeze-drying a sample containing the cells as described above and subsequently storing the sample at a storage temperature greater than about 193K, greater than about 253K and even greater than about 273K for a period of time greater than 1 day, greater than one week and even greater than 6 weeks.
- cryoprotectant that is solid at the storage temperature.
- cryoprotectant is trehalose.
- the device of the present invention is substantially a device for directional cooling of biological samples as described in U.S. 5,873,254 but additionally including a means of agitating the vessel in which the biological sample to be frozen is contained.
- Agitation of the sample can be performed in a large number of ways. Conceivably shaking, vibrating, rocking, rolling can all be implemented as agitation methods to ensure that the biological sample is mixed during the freezing process and as a result the thermal homogeneity in the cooling front. Simplest to implement is rotation of the vessel, especially when the axis of rotation is parallel to the direction of advancement and thus perpendicular to the cooling front. Intuitively it seems that rotation perpendicular to the cooling front is the agitation method that allows for the greatest thermal homogeneity within the cooling front without disrupting the temperature gradient within the biological sample.
- the word vessel as used herein is non-limiting and refers to a vessel in the usual sense of the word and includes such objects as bags, bottles, flasks, jars, tubes, boxes, sacks and other containers. While not wishing to be held to any one theory, it is believed that the agitation of the sample during directional cooling modifies the thermal homogeneity during the freezing process as well as the crystal morphology. Less cell damage occurs during the freezing process. When the sample does not entirely fill the test tube, the total surface area of the frozen sample is increased, allowing quick and efficient lyophilization without damaging cell membranes.
- a device for freezing a sample including a vessel for containing the sample, a mechanism for moving said vessel along a track and a refrigeration means for imposing a laterally variable temperature gradient along the track, the refrigeration means including a plurality of thermally conductive blocks substantially- enclosing the track
- the device also includes a a means of agitating the vessel when moving along the track.
- the vessel is a tube with a diameter of greater than about 6 mm.
- the means of agitating the vessel includes a motor, such as an electrical motor.
- the means of agitating the ⁇ 'essel includes a control device to vary the intensity of agitation of the vessel.
- the means of agitating the vessel are in fact means of rotating the vessel.
- rotations is around an axis substantially parallel to the track, that is substantially perpendicular to a cold front generated inside the sample when the device is operated (vide infra).
- the rotation is caused by a motor, such as an electrical motor.
- the device of the present invention is fitted with a control device to vary the rate of rotation of the vessel.
- FIGS. 1 are schematic depictions of a directional cooling device
- FIG. 2 is a schematic depiction of a cooling device of the present invention.
- the present invention is directed to a method and a device for the freezing of cells in solution so that the frozen cells can be lyophilized, stored and subsequently rehydrated.
- the principles and uses of the method according to the present invention may be better understood with reference to description, the experimental results and the drawings, in which like reference numerals refer to like parts throughout all of the figures. It is understood that the descriptions herein are illustrative and not intended to restrict the present invention to the specific details set forth below.
- FIG 2 is depicted a cooling device 50 of the present invention.
- Clearly device 50 is similar to device 10 depicted in Figures 1.
- rod 28 is tipped with engaging tines 54 and can be made to rotate around an axis parallel to track 16 by electrical rotation motor 52.
- the speed by which rotation motor 52 rotates rod 28 is determined by rotation controller 56;
- Engaging tines 54 are configured to engage following end 36 of vessel 12 when vessel 12 is on track 16.
- the method of the present invention When the method of the present invention is used to freeze a sample, it is not necessary to add cryoprotectant to the sample. For a given sample, freezing according to the method of the present invention gives a significant improvement of post-thawing, and if lyophilized, post-rehydration cell viability when compared to freezing using the teachings of U.S. 5,873,254. That said, the method of the present invention is compatible with the use of cryoprotectants when and if desired.
- large volumes of biological sample can be prepared for cryogenic storage at one time, a significant improvement of the teachings of U.S. 5,873,254.
- the much greater volumes that can be frozen are a result of the fact that agitation of the sample-containing vessel during the freezing process allows greater thermal homogeneity within the sample, allowing a vessel with a significantly greater diameter to be used.
- the largest practical vessel when using the teachings of U.S. 5,873,254 is about 5 cm long with a diameter of no more than about 0.5 cm.
- vessels with diameters of greater than 6 mm, and even diameters of greater than 25 mm are typically used with no statistically significant reduction of post-rehydration viability.
- Increased sample volume coupled with a faster cooling rate described above allows for a significant throughput increase.
- freezing is a preparatory step for lyophilization.
- the vessel not be filled completely with biological sample.
- the biological sample fills only 90% of the vessel, more preferably only 50% of the vessel and most preferably only 30% of the vessel is filled.
- the frozen sample so produced has a very high surface area. The high surface area, as well as the fact that no cryoprotectant needs be added, means that subsequent lyophilization is quick and efficient. A combination of a high freezing-rate, high sample volume, and fast lyophilization allows for a significant throughput increase.
- a sample lyophilized after being frozen according to the method of the present invention can be stored at relatively high temperatures for extended periods of time without significant post-hydration viability loss.
- In general storage temperature depends on the water loss. If a sample loses up to about 90% of the original weight due to lyophilization, the sample is stored at temperatures below freezing. If a sample loses more than about 90% of the original weight due to lyophilization, it may be possible to store the sample at high temperatures (277K or even room temperature).
- Leukocytes were separated from whole blood using Histopaq ⁇ e 1077. The samples were put in standard 15ml test tubes and centrifuged for 30 minutes at 1000 G. The leukocyte layer was transferred to a different test tube and again centrifuged for 10 minutes at 250 G. The supernatant was discarded and the leukocyte pellet was washed with PBS and again centrifuged, as described above.
- a leukocyte suspension was prepared by dissolving the leukocyte pellet in a solution containing 50% PBS (phosphate buffered solution) and 50% plasma. Trehalose was added so as to get a 0.1M trehalose concentration.
- PBS phosphate buffered solution
- 2.8 ml of the leukocyte suspension was transferred to each of three 12 ml glass test tube and frozen in a device of the present invention, a modified (resembling device 50 depicted in Figure 2) MTG freezing apparatus manufactured by IMT, Israel.
- the thermal gradient in the cooling unit was set to 0.43°C/mm in all three cases with a final temperature of 203K.
- the rate of test tube insertion was 0.02, 0.2 and 2.0 mm/sec, yielding cooling rates of 0.5, 5.1 and 51 °C/min, respectively.
- the test tubes were rotated at a rate of 32 rpm.
- test tube was taken from each test tube to test for cell viability, and the test tubes transferred to a lyophilizer. Lyophilization was performed at a chamber temperature of 238K and a condenser temperature of 191K for 3 hours and for 24 hours. A sample was taken from each test tube to test for viability after 3 hours lyophilization and after 24 hours lyophilization. After 24 hours of lyophilization test tube A lost 76% of the original sample weight, test tube B lost 77% of the original sample weight and sample C lost 87% of the original sample weight.
- Viability %; test tube Interface Cooling weight sample 1 sample 2 sample 3 velocity rate loss (freeze/thaw) lyophilize lyophilize
- test tubes D, E, F and G were prepared as above to examine the influence of a different interface velocity at a cooling rate of 5.1 °C / min cases to a final temperature of 253K, 238K, 203K, 173K, respectively. Samples were taken at intervals as described above. The test tubes were lyophilized to complete dryness (loss of greater than 92% of the initial weight) by lyophilization for 72 hours. After 72 hours lyophilization an additional sample was taken from each test tube. The results are presented in Table 2.
- test tube Interface sample 1 sample 2 sample 3 sample 4 velocity (freeze/thaw) lyophilize lyophilize lyophilize lyophilize
- test tubes FI, I and J Six further identical test tubes were prepared as above to examine the influence of a different rotation velocities at a cooling rate of 5.1 °C / min and an interface velocity of 0.2 mm/sec (test tubes FI, I and J) to a final temperature of 203K and 0.48 mm/sec (test tubes K,
- test tube rotation sample 1 sample 2 sample 3 sample 4 rate (freeze/thaw) lyophilize lyophilize lyophilize lyophilize
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/488,414 US7659111B2 (en) | 2002-06-27 | 2002-09-05 | Method for freezing viable cells |
AU2002337480A AU2002337480A1 (en) | 2001-09-06 | 2002-09-05 | Improved method for freezing viable cells |
EP02772760A EP1428008B1 (en) | 2001-09-06 | 2002-09-05 | Improved method for freezing viable cells |
AT02772760T ATE542123T1 (en) | 2002-06-27 | 2002-09-05 | IMPROVED METHOD FOR FREEZING VIABLE CELLS |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31714701P | 2001-09-06 | 2001-09-06 | |
US60/317,147 | 2001-09-06 | ||
US39157502P | 2002-06-27 | 2002-06-27 | |
US60/391,575 | 2002-06-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003020874A2 true WO2003020874A2 (en) | 2003-03-13 |
WO2003020874A3 WO2003020874A3 (en) | 2003-09-25 |
Family
ID=26980806
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL2002/000738 WO2003020874A2 (en) | 2001-09-06 | 2002-09-05 | Improved method for freezing viable cells |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1428008B1 (en) |
AU (1) | AU2002337480A1 (en) |
WO (1) | WO2003020874A2 (en) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060099567A1 (en) * | 2004-04-08 | 2006-05-11 | Biomatrica, Inc. | Integration of sample storage and sample management for life science |
WO2008006621A1 (en) * | 2006-07-14 | 2008-01-17 | Rebholz, Erich | Method and installation for temporarily storing microbes |
US7331186B2 (en) | 2002-06-27 | 2008-02-19 | I.M.T. Interface Multigrad Technology Ltd | Changing the temperature of a liquid sample and a receptacle useful therefor |
US7892726B2 (en) | 2004-06-07 | 2011-02-22 | Core Dynamics Limited | Method for sterilizing lyophilized eukaryotic anuclear cells with gamma irradiation |
US7935478B2 (en) | 2004-02-02 | 2011-05-03 | Core Dynamics Limited | Biological material and methods and solutions for preservation thereof |
US20110183372A1 (en) * | 2008-07-11 | 2011-07-28 | Health Protection Agency | Stimulated cell standards |
WO2011098996A2 (en) | 2010-02-09 | 2011-08-18 | Core Dynamics Ltd. | Improved method for changing the temperature of a biological specimen |
US8037696B2 (en) | 2004-08-12 | 2011-10-18 | Core Dynamics Limited | Method and apparatus for freezing or thawing of a biological material |
US8196416B2 (en) | 2004-02-02 | 2012-06-12 | Core Dynamics Limited | Device for directional cooling of biological matter |
US8198085B2 (en) | 2005-08-03 | 2012-06-12 | Core Dynamics Limited | Somatic cells for use in cell therapy |
US9725703B2 (en) | 2012-12-20 | 2017-08-08 | Biomatrica, Inc. | Formulations and methods for stabilizing PCR reagents |
US9845489B2 (en) | 2010-07-26 | 2017-12-19 | Biomatrica, Inc. | Compositions for stabilizing DNA, RNA and proteins in saliva and other biological samples during shipping and storage at ambient temperatures |
US9999217B2 (en) | 2010-07-26 | 2018-06-19 | Biomatrica, Inc. | Compositions for stabilizing DNA, RNA, and proteins in blood and other biological samples during shipping and storage at ambient temperatures |
US10064404B2 (en) | 2014-06-10 | 2018-09-04 | Biomatrica, Inc. | Stabilization of thrombocytes at ambient temperatures |
US10568317B2 (en) | 2015-12-08 | 2020-02-25 | Biomatrica, Inc. | Reduction of erythrocyte sedimentation rate |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201705652D0 (en) | 2017-04-07 | 2017-05-24 | Asymptote Ltd | Cryopreservation apparatus and methods |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4874690A (en) * | 1988-08-26 | 1989-10-17 | Cryopharm Corporation | Lyophilization of red blood cells |
US5059518A (en) * | 1988-10-20 | 1991-10-22 | Coulter Corporation | Stabilized lyophilized mammalian cells and method of making same |
US5071598A (en) * | 1987-12-03 | 1991-12-10 | California Institute Of Technology | Cryoprotective reagent |
US5364756A (en) * | 1990-09-12 | 1994-11-15 | Lifecell | Method of cryopreserving a suspension of biological material |
US5873254A (en) * | 1996-09-06 | 1999-02-23 | Interface Multigrad Technology | Device and methods for multigradient directional cooling and warming of biological samples |
US6073540A (en) * | 1998-11-10 | 2000-06-13 | Fmc Corporation | Apparatus for heating or cooling product containers |
JP2000189155A (en) * | 1998-12-25 | 2000-07-11 | Livestock Improvement Association Of Japan Inc | Preservation of mammalian embryo or ovum and thawing dilution of frozen mammalian embryo or ovum |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU1806692C (en) * | 1990-12-19 | 1993-04-07 | Украинский Научно-Исследовательский Институт По Племенному Делу В Животноводстве | Method and device for cryoconservation of farm animal semen |
-
2002
- 2002-09-05 WO PCT/IL2002/000738 patent/WO2003020874A2/en not_active Application Discontinuation
- 2002-09-05 AU AU2002337480A patent/AU2002337480A1/en not_active Abandoned
- 2002-09-05 EP EP02772760A patent/EP1428008B1/en not_active Expired - Lifetime
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5071598A (en) * | 1987-12-03 | 1991-12-10 | California Institute Of Technology | Cryoprotective reagent |
US4874690A (en) * | 1988-08-26 | 1989-10-17 | Cryopharm Corporation | Lyophilization of red blood cells |
US5059518A (en) * | 1988-10-20 | 1991-10-22 | Coulter Corporation | Stabilized lyophilized mammalian cells and method of making same |
US5364756A (en) * | 1990-09-12 | 1994-11-15 | Lifecell | Method of cryopreserving a suspension of biological material |
US5873254A (en) * | 1996-09-06 | 1999-02-23 | Interface Multigrad Technology | Device and methods for multigradient directional cooling and warming of biological samples |
US6073540A (en) * | 1998-11-10 | 2000-06-13 | Fmc Corporation | Apparatus for heating or cooling product containers |
JP2000189155A (en) * | 1998-12-25 | 2000-07-11 | Livestock Improvement Association Of Japan Inc | Preservation of mammalian embryo or ovum and thawing dilution of frozen mammalian embryo or ovum |
Non-Patent Citations (2)
Title |
---|
DATABASE WPI Derwent Publications Ltd., London, GB; AN 1994-223708, XP002961154 & SU 1 806 692 A1 (ZORIN ET AL.) 07 April 1993 * |
See also references of EP1428008A2 * |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7331186B2 (en) | 2002-06-27 | 2008-02-19 | I.M.T. Interface Multigrad Technology Ltd | Changing the temperature of a liquid sample and a receptacle useful therefor |
US8196416B2 (en) | 2004-02-02 | 2012-06-12 | Core Dynamics Limited | Device for directional cooling of biological matter |
US7935478B2 (en) | 2004-02-02 | 2011-05-03 | Core Dynamics Limited | Biological material and methods and solutions for preservation thereof |
US8512941B2 (en) | 2004-02-02 | 2013-08-20 | Core Dynamics Limited | Biological material and methods and solutions for preservation thereof |
US20060099567A1 (en) * | 2004-04-08 | 2006-05-11 | Biomatrica, Inc. | Integration of sample storage and sample management for life science |
US7892726B2 (en) | 2004-06-07 | 2011-02-22 | Core Dynamics Limited | Method for sterilizing lyophilized eukaryotic anuclear cells with gamma irradiation |
US8037696B2 (en) | 2004-08-12 | 2011-10-18 | Core Dynamics Limited | Method and apparatus for freezing or thawing of a biological material |
US8198085B2 (en) | 2005-08-03 | 2012-06-12 | Core Dynamics Limited | Somatic cells for use in cell therapy |
WO2008006621A1 (en) * | 2006-07-14 | 2008-01-17 | Rebholz, Erich | Method and installation for temporarily storing microbes |
US20110183372A1 (en) * | 2008-07-11 | 2011-07-28 | Health Protection Agency | Stimulated cell standards |
JP2011527192A (en) * | 2008-07-11 | 2011-10-27 | ヘルス プロテクション エージェンシー | Stimulator cell standard |
CN102144165A (en) * | 2008-07-11 | 2011-08-03 | 英国健康保护局 | Stimulated cell standards |
US9267956B2 (en) * | 2008-07-11 | 2016-02-23 | Secretary Of State For Health | Stimulated cell standards |
WO2011098996A2 (en) | 2010-02-09 | 2011-08-18 | Core Dynamics Ltd. | Improved method for changing the temperature of a biological specimen |
US9845489B2 (en) | 2010-07-26 | 2017-12-19 | Biomatrica, Inc. | Compositions for stabilizing DNA, RNA and proteins in saliva and other biological samples during shipping and storage at ambient temperatures |
US9999217B2 (en) | 2010-07-26 | 2018-06-19 | Biomatrica, Inc. | Compositions for stabilizing DNA, RNA, and proteins in blood and other biological samples during shipping and storage at ambient temperatures |
US9725703B2 (en) | 2012-12-20 | 2017-08-08 | Biomatrica, Inc. | Formulations and methods for stabilizing PCR reagents |
US10064404B2 (en) | 2014-06-10 | 2018-09-04 | Biomatrica, Inc. | Stabilization of thrombocytes at ambient temperatures |
US10772319B2 (en) | 2014-06-10 | 2020-09-15 | Biomatrica, Inc. | Stabilization of thrombocytes at ambient temperatures |
US11672247B2 (en) | 2014-06-10 | 2023-06-13 | Biomatrica, Inc. | Stabilization of thrombocytes at ambient temperatures |
US10568317B2 (en) | 2015-12-08 | 2020-02-25 | Biomatrica, Inc. | Reduction of erythrocyte sedimentation rate |
US11116205B2 (en) | 2015-12-08 | 2021-09-14 | Biomatrica, Inc. | Reduction of erythrocyte sedimentation rate |
Also Published As
Publication number | Publication date |
---|---|
EP1428008A2 (en) | 2004-06-16 |
AU2002337480A1 (en) | 2003-03-18 |
WO2003020874A3 (en) | 2003-09-25 |
EP1428008B1 (en) | 2012-01-18 |
EP1428008A4 (en) | 2004-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7659111B2 (en) | Method for freezing viable cells | |
EP1428008B1 (en) | Improved method for freezing viable cells | |
CA2051092C (en) | Method and apparatus for cryopreparation, dry stabilization and rehydration of biological suspensions | |
JP4889602B2 (en) | Storage and storage media for biological materials | |
Shukla | Freeze drying process: A review | |
Gaidhani et al. | Lyophilization/freeze drying–a review | |
CA2640590C (en) | Lyophilization system and method | |
US5736313A (en) | Method of lyophilizing platelets by incubation with high carbohydrate concentrations and supercooling prior to freezing | |
CA2640833C (en) | Method of inducing nucleation of a material | |
US9642353B2 (en) | Desiccated biologics and methods of preparing the same | |
US7153472B1 (en) | Preservation and formulation of bioactive materials for storage and delivery in hydrophobic carriers | |
US20060019233A1 (en) | Delivery of high cell mass in a syringe and related methods of cryopreserving cells | |
AU2001268057A1 (en) | Preservation and storage medium for biological materials | |
WO2004011616A2 (en) | Systems and methods for cell preservation | |
WO2006029467A1 (en) | Rapid freeze drying process | |
Kumar et al. | Fundamentals and applications of lyophilization | |
Xiao et al. | Freeze-drying of mononuclear cells and whole blood of human cord blood | |
CN116694581A (en) | Freeze-drying protective agent for vibrio harveyi phage V-YDF132 and preservation method thereof | |
Khandagale et al. | Lyophilization Technique: A Review | |
Parthasarathy | Freeze-substitution | |
Kendrick | Preservation of fleshy fungi for taxonomy | |
Mazur | Mechanisms of injury in frozen and frozen-dried cells | |
Chiotellis | Lyophilization Technique for Preparing Radiopharmaceutical Kits | |
Meryman | History and development of freeze-drying | |
Pandhare et al. | REVIEW ON: LYOPHILIZATION PROCESS OF PHARMACEUTICALS. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VC VN YU ZA ZM Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 10488414 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002772760 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002772760 Country of ref document: EP |
|
NENP | Non-entry into the national phase in: |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |